Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    23982301 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Evaluation of the Initial Prescription of Ketamine and Milnacipran for Depression in Palliative Care
Condition: Depression
Interventions: Drug: Ketamine;   Drug: Milnacipran;   Drug: Placebo
2 Recruiting Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
Condition: Depressive Disorder, Treatment-Resistant
Intervention: Drug: Ketamine
3 Enrolling by invitation Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy
Condition: Depressive Disorder
Interventions: Drug: Ketamine;   Drug: Placebo
4 Recruiting Spreading Depolarization and Ketamine Suppression
Conditions: Cortical Spreading Depolarization;   Cortical Spreading Depression;   Subarachoid Hemorrhage;   Traumatic Brain Injury
Intervention: Drug: ketamine
5 Completed
Has Results
Optimization of IV Ketamine for Treatment Resistant Depression
Conditions: Major Depressive Disorder (MDD);   Treatment Resistant Depression (TRD)
Interventions: Drug: Ketamine;   Drug: Midazolam

Indicates status has not been verified in more than two years